FierceBiotech 2026年3月11日 Salspera plans $91M IPO to fund phase 3 studies of salmonella-based cancer therapy
FierceBiotech 2026年3月10日 Lilly pledges $500M to South Korea biopharma industry, following Roche’s lead
FierceBiotech 2026年3月10日 Molecular glue biotech shutters after ‘brutal’ few years for early-stage companies
FierceBiotech 2026年3月10日 FDA approves leucovorin for ultrarare cerebral folate deficiency subset without clinical trial
FierceBiotech 2026年3月10日 Republican senator slams FDA rare disease rebuffs, pledges to investigate recent actions: Bloomberg
FierceBiotech 2026年3月10日 FDA reconsidering Capricor’s snubbed DMD cell therapy after 'lifting' rejection
FierceBiotech 2026年3月9日 Tenacia builds $308M biobucks deal with Rapport to develop epilepsy drug in greater China
FierceBiotech 2026年3月9日 Roche's oral SERD flunks phase 3 trial in 1st-line breast cancer, raising questions of mechanism's limits
FierceBiotech 2026年3月9日 Italy's Alfasigma pens $690M deal for GSK itching drug awaiting FDA approval decision